Printer Friendly

Deriving new drugs from thalidomide.

Thalidomide, a nausea-fighting sedative synthesized during the 1950s but never approved for use in the United States because of its fetus-harming effects, is spawning a new generation of drugs that can treat inflammation and immune system disorders (SN: 12/24&31/94, p.424).

George W. Muller and David I. Stirling, chemists at Celgene Corp. in Warren, N.J., reengineered thalidomide to create a new series of therapeutic agents.

The researchers have designed the drugs, they say, to regulate the body's production of tumor necrosis factor alpha. This protein plays a key role in inflammatory and immunological disorders such as rheumatoid arthritis, lupus, inflammatory bowel disease, and leprosy.

Scientists at Johns Hopkins University in Baltimore are currently studying several of these new Celgene agents for treatment of graft-versus-host disease, which often follows bone marrow transplants, Muller adds.

In designing these new molecules, Muller and Stirling said, they improved the potency of the portion of thalidomide exhibiting medicinal properties and removed the segment causing birth defects.
COPYRIGHT 1995 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Chemistry; new thalidomide agents regulate body's ability to produce tumor necrosis factor alpha, a major contributor to inflammatory and immunological disorders
Author:Lipkin, Richard
Publication:Science News
Article Type:Brief Article
Date:Sep 9, 1995
Words:165
Previous Article:Drugs target RNA to kill tumors ... and block HIV.
Next Article:Electron beam cleans dirty water.
Topics:


Related Articles
Human gene therapy wins crucial victory.
The return of thalidomide: a shunned compound makes a scientific comeback.
Thalidomide heals ulcers.
Thalidomide combats myeloma blood cancer.
Thalidomide: Important Patient Information.
Is thalidomide "good" or "bad"?

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters